Literature DB >> 11518464

Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada.

Y Chen1, R Semenciw, E Kliewer, Y Shi, Y Mao.   

Abstract

Second primary breast cancer is of importance because of the increasing incidence of first primary breast cancer and improved survival. There is lack of information on the disease in Canada. We studied 14,220 women with a first primary breast cancer (invasive only) diagnosed during the period from 1970 to 1997, in Manitoba, Canada. A breast cancer was considered to be a second primary if it was an invasive lesion diagnosed at least six months after the diagnosis of an initial primary breast cancer. The incidence rate of second primary breast cancer was approximately six per 1,000 person-years, and the cumulative incidence during the 28-year study period was 14.3%. Average age at diagnosis of first primary breast cancer had increased significantly since 1970. The incidence was higher in 1975-1979, and there was no significant difference among other study periods after adjustment for the age at diagnosis of first primary breast cancer. Standardized incidence ratios showed no significant difference among six age groups after adjusting for calendar year. However, women with a first primary breast cancer had an increased risk of developing a second primary breast cancer compared with the risk of developing a first primary breast cancer among the general female population. The SIR was markedly greater among women who had a first primary breast cancer before the age of 40 years, and decreased significantly with increasing age at diagnosis of first primary breast cancer. The data provide epidemiological information on second primary breast cancer risk for the general female population in Manitoba, Canada.

Entities:  

Mesh:

Year:  2001        PMID: 11518464     DOI: 10.1023/a:1010665603732

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.

Authors:  Rinaa S Punglia; Michael J Hassett
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

2.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

3.  Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.

Authors:  M B Hannouf; M Brackstone; B Xie; G S Zaric
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

4.  Second primary breast cancer occurrence according to hormone receptor status.

Authors:  Allison W Kurian; Laura A McClure; Esther M John; Pamela L Horn-Ross; James M Ford; Christina A Clarke
Journal:  J Natl Cancer Inst       Date:  2009-07-09       Impact factor: 13.506

5.  A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population.

Authors:  S Vidal-Millan; I Zeichner-Gancz; D Flores-Estrada; B E Vela-Rodríguez; M I Vazquez-López; C D Robles-Vidal; M T Ramirez-Ugalde; M Chávez-MacGregor
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

7.  Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.

Authors:  Maria E C Sandberg; Per Hall; Mikael Hartman; Anna L V Johansson; Sandra Eloranta; Alexander Ploner; Kamila Czene
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Options for early breast cancer follow-up in primary and secondary care - a systematic review.

Authors:  Frances Taggart; Peter Donnelly; Janet Dunn
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

9.  A constant risk for familial breast cancer? A population-based family study.

Authors:  Kamila Czene; Marie Reilly; Per Hall; Mikael Hartman
Journal:  Breast Cancer Res       Date:  2009-05-20       Impact factor: 6.466

10.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.